Sales 2024 * 157B 117M Sales 2025 * 229B 170M Capitalization 245B 182M
Net income 2024 * 12B 8.92M Net income 2025 * 34B 25.26M EV / Sales 2024 * 1.79 x
Net Debt 2024 * 36B 26.75M Net Debt 2025 * 27.8B 20.66M EV / Sales 2025 * 1.19 x
P/E ratio 2024 *
20.7 x
P/E ratio 2025 *
7.1 x
Employees 218
Yield 2024 *
-
Yield 2025 *
-
Free-Float 70.89%
More Fundamentals * Assessed data
Dynamic Chart
Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd. CI
Ray Co., Ltd. announced that it expects to receive KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd. CI
Ray Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Ray Co., Ltd. announced that it has received KRW 31.5 billion in funding CI
Ray Co., Ltd. announced that it expects to receive KRW 31.5 billion in funding CI
Optical Biosystems, Inc. announced that it has received $20 million in funding from a group of investors CI
Ray Co., Ltd.(KOSDAQ:A228670) added to S&P Global BMI Index CI
Ray Co., Ltd.(KOSDAQ:A228670) added to S&P Global BMI Index CI
Ray Co., Ltd. has completed an IPO in the amount of KRW 20 billion. CI
Ray Co., Ltd. has filed an IPO. CI
LED Dental Launches New RIOSensor Intraoral Radiography System from Ray Co., Ltd CI
RAY Co., Ltd. announced that it has received funding from BlueRun Ventures. CI
SVIC No.6 New Technology Business Investment L.L.P., a fund of Samsung Venture Investment Corporation, sold 64.61% stake in RAY Co., Ltd. for KRW 9.2 billion. CI
LED Dental Inc. Signs Exclusive Canadian Distribution Agreement with Samsung's Ray Co CI
LED Medical Inc. Announces Partnership Between LED Dental Ltd and RAY Co., Ltd CI
More news
1 day+0.63%
1 week-4.76%
Current month-2.68%
1 month-1.48%
3 months-29.98%
6 months-26.61%
Current year-29.98%
More quotes
1 week
14 760.00
Extreme 14760
17 270.00
1 month
14 760.00
Extreme 14760
17 680.00
Current year
14 760.00
Extreme 14760
25 100.00
1 year
14 760.00
Extreme 14760
42 150.00
3 years
14 150.00
Extreme 14150
42 150.00
5 years
11 825.00
Extreme 11825
42 150.00
10 years
11 825.00
Extreme 11825
42 150.00
More quotes
Managers TitleAgeSince
Founder 51 04-10-05
Chief Tech/Sci/R&D Officer 51 08-05-31
Sales & Marketing 50 -
Members of the board TitleAgeSince
Founder 51 04-10-05
Chief Tech/Sci/R&D Officer 51 08-05-31
Director/Board Member 52 06-09-30
More insiders
Date Price Change Volume
24-03-28 16,000 +0.63% 299,233
24-03-27 15,900 +7.29% 752,585
24-03-26 14,820 -12.67% 1,277,827
24-03-25 16,970 +0.24% 92,534
24-03-22 16,930 +0.77% 45,136

End-of-day quote Korea S.E., March 27, 2024

More quotes
Ray Co.,Ltd is a Korea-based company mainly engaged in the development, production and distribution of dental imaging medical devices. Along with its subsidiaries, the Company manufactures and sells digital diagnostic systems and digital therapy solution products. Digital diagnostic systems include dental radiography equipments such as x-ray systems and cone beam computed tomography (CBCT) systems. Digital therapy solutions include three dimensional (3D) scanning, dental computer aided design (CAD), and 3D printers used in prosthodontics, orthodontics, and implant surgery. The Company distributes its products within domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
16,000 KRW
Average target price
35,000 KRW
Spread / Average Target
+118.75%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Ray Co., Ltd. - Korea S.E.